25.34
1.17%
-0.30
Finanzdaten der 4D Molecular Therapeutics Inc-Aktie (FDMT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
100.09%
-0.019
|
20.20 | 0.239 | 0.298 | 1.247 |
Operating Expenses |
7.18%
36.63
|
34.18 | 32.38 | 30.40 | 29.97 |
Benefits Costs and Expenses |
32.26
|
- | - | 28.98 | 28.63 |
Costs And Expenses |
5.60%
32.26
|
34.18 | 32.38 | 28.98 | 28.63 |
Depreciation and Amortization |
10.87%
1.102
|
0.994 | 1.079 | 1.029 | 1.014 |
Operating Income/Loss |
162.29%
-36.65
|
-13.97 | -32.14 | -30.11 | -28.72 |
Nonoperating Income/Loss |
17.51%
4.369
|
3.718 | 2.52 | 1.424 | 1.341 |
Income/Loss From Continuing Operations Before Tax |
259.79%
-32.28
|
20.20 | -29.62 | -28.68 | -27.38 |
Income/Loss From Continuing Operations After Tax |
214.77%
-32.28
|
-10.26 | -29.62 | -28.68 | -27.38 |
Net Income/Loss
|
214.77%
-32.28
|
-10.26 | -29.62 | -28.68 | -27.38 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
97.05%
1.2457
|
42.26 | 38.34 | 32.72 | 0.0461 |
Diluted Average Shares |
97.05%
1.2457
|
42.26 | 38.34 | 32.72 | 0.0461 |
Basic Earnings Per Share |
220.83%
-0.77
|
-0.24 | -0.77 | -0.88 | -0.84 |
Diluted Earnings Per Share |
220.83%
-0.77
|
-0.24 | -0.77 | -0.88 | -0.84 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):